ROYAL BANK OF CANADA - AEVI GENOMIC MEDICINE INC ownership

AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 51 filers reported holding AEVI GENOMIC MEDICINE INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AEVI GENOMIC MEDICINE INC
ValueSharesWeighting
Q4 2019$0
-100.0%
500
-75.0%
0.00%
Q4 2018$1,000
-50.0%
2,000
-4.3%
0.00%
Q3 2018$2,0000.0%2,089
+4.4%
0.00%
Q2 2018$2,000
-50.0%
2,0000.0%0.00%
Q1 2018$4,000
+100.0%
2,000
-1.2%
0.00%
Q4 2017$2,000
-33.3%
2,0250.0%0.00%
Q3 2017$3,0000.0%2,025
+1.2%
0.00%
Q2 2017$3,000
-50.0%
2,000
-36.8%
0.00%
Q1 2017$6,000
-68.4%
3,165
-14.7%
0.00%
Q4 2016$19,0003,7100.00%
Other shareholders
AEVI GENOMIC MEDICINE INC shareholders Q2 2017
NameSharesValueWeighting ↓
22NW, LP 155,000$206,0000.12%
Birchview Capital, LP 128,000$170,0000.09%
CARL DOMINO INC 43,273$58,0000.07%
NORTHERN CAPITAL MANAGEMENT LLC 106,050$141,0000.05%
ELEMENT CAPITAL MANAGEMENT LLC 124,423$165,0000.03%
Baker Brothers Advisors 1,618,089$2,152,0000.02%
SIMON QUICK ADVISORS, LLC 24,390$32,0000.02%
ARTHUR M. COHEN & ASSOCIATES, LLC 31,390$42,0000.02%
WHITE PINE CAPITAL LLC 20,000$27,0000.01%
LMR Partners LLP 112,265$149,0000.01%
View complete list of AEVI GENOMIC MEDICINE INC shareholders